Abstract:Background Peripheral arterial disease (PAD) is highly prevalent and particularly in elders, smokers, diabetics or patients with systemic atherosclerosis. Apart from the surgery and medication, stem cell transplantation offers promising approaches for therapeutic angiogenesis and tissue repair. In this study we try to use in vivo multimodality molecular imaging strategies to investigate adipose tissue-derived mesenchymal stem cells (MSCs) survival, function and relative mechanism. Method MSCs were cultured from murine adipose tissue from transgenic mice, which carried double reporter genes: firefly luciferase (Fluc) and enhanced green fluorescent protein (eGFP), by collagenase digestion method. Hindlimb ischaemia animal model was created in male nude mice by ligating the proximal and distal femoral artery. MSCs (1×105) along with/without VEGF (0.4 ng) were transplanted into ischaemic hindlimb. The animals were subjected to be imaged by bioluminescence imaging and CT scan. Laser Doppler perfusion imaging (LDPI) were used to show the spatiotemporal images of peripheral tissue blood perfusion. Micro-CT, histological and molecular analysis were tested to confirm the cells9 location and angiogenesis anatomically and mechanically. Result The colour-coded index of LDPI was significantly higher in the MSCs-transplanted group than that in the control group from day 3 to 28 post cell transplantation. On day 3 after transplantation, the bioluminescence signals in MSCs with VEGF group were 4.6×106±2.5×105 photons/s/cm2/sr, while in MSCs group were 2.8×106±3.1×105 photons/s/cm2/sr, respectively (p<0.01 vs control). The signals of bioluminescence increased gradually from POD 3 to day 21, which proved survival and proliferation of the MSCs in the host. The group treated with MSCs and VEGF showed higher signals than that injected by MSCs only, which indicated the reinforcement of VEGF. Micro-CT angiography demonstrated more angiogenesis in the hindlimbs of the treated mice on day 21, which were also confirmed by molecular analysis. Histological analysis showed that MSCs therapy recovered vessel density compared with the control group. Conclusion Bioluminescence fusion with CT scan provides higher detailed 3D imaging for monitoring MSCs in vivo. Angiogenesis activator VEGF might promote MSCs9 beneficial function for hindlimb ischaemia therapy.

Overexpression of Hsp 70 enhances MSCs survival and therapeutic efficiency in hindlimb ischemia

Heat Shock Protein 90 Stimulates Rat Mesenchymal Stem Cell Migration Via PI3K/Akt and ERK1/2 Pathways

Therapeutic Angiogenesis of Bone Marrow Mononuclear Cells (mncs) and Peripheral Blood Mncs: Transplantation for Ischemic Hindlimb

Abstract 723: Agonist of Growth Hormone Releasing Hormone Enhances Angiogenic Therapy by Mesenchymal Stem Cells

Angiopoietin-1 Preconditioning Enhances Survival and Functional Recovery of Mesenchymal Stem Cell Transplantation

Transplantation of Hypoxia Preconditioned Bone Marrow Mesenchymal Stem Cells Enhances Angiogenesis and Neurogenesis after Cerebral Ischemia in Rats.

Enhancing Retention of Human Bone Marrow Mesenchymal Stem Cells with Prosurvival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia.

Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model

Heat-Shock Proteins Can Potentiate the Therapeutic Ability of Cryopreserved Mesenchymal Stem Cells for the Treatment of Acute Spinal Cord Injury in Dogs

E0204 Heat Shock Protein 90 Enhances Rat Mesenchymal Stem Cells Migration Via PI3KAkt and ERK12 Pathways

Hypoxia pretreatment improves the therapeutic potential of bone marrow mesenchymal stem cells in hindlimb ischemia via upregulation of NRG-1

Mesenchymal stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia

Abstract 328: Enhanced Therapeutic Effects of Mesenchymal Stem Cells for Hindlimb Ischemia by a Nitric Oxide Hydrogel Through Mesenchymal-endothelial Transition

E-Selectin-Overexpressing Mesenchymal Stem Cell Therapy Confers Improved Reperfusion, Repair, and Regeneration in a Murine Critical Limb Ischemia Model

Repeated intravenous administration of hiPSC-MSCs enhance the efficacy of cell-based therapy in tissue regeneration

Transplantation Of Mesenchymal Stem Cells Enhances Angiogenesis After Ischemic Limb Injury In Mice

Abstract 490: Enhanced Therapeutic Effects of MSC-derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment

IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia

Local delivery of cardiac stem cells overexpressing HIF-1α promotes angiogenesis and muscular tissue repair in a hind limb ischemia model

E0009 Multimodality Molecular Imaging of Adipose-Derived Mesenchymal Stem Cells with VEGF in Hindlimb Ischaemia Mice

Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice